Page 1322 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1322

References     7


                   193. Cataland SR, Jin M, Lin S, et al. Cyclosporin and plasma     210. Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi
                      exchange in thrombotic thrombocytopenic purpura: long-term   V. Use of eculizumab for atypical haemolytic uraemic syndrome
                      follow-up with serial analysis of ADAMTS13 activity.  Br J   and C3 glomerulopathies. Nat Rev Nephrol. 2012;8(11):643-657.
                      Haematol. 2007;139(3):486-493.                       211. Ridolfi RL, Hutchins GM, Bell WR. The heart and cardiac
                   194. Enami T, Suzuki T, Ito S, et al. Successful treatment of refractory   conduction system in thrombotic thrombocytopenic purpura.
                      thrombotic thrombocytopenic purpura with cyclosporine and   A clinicopathologic study of 17 autopsied patients. Ann Intern
                      corticosteroids in a patient with systemic lupus erythematosus and   Med. 1979;91(3):357-363.
                      antibodies to ADAMTS13. Intern Med. 2007;46(13):1033-1037.    212. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Clinical
                   195. Cataland SR, Jin M, Zheng XL, George JN, Wu HM. An evalua-  cardiac involvement in thrombotic thrombocytopenic purpura:
                      tion of cyclosporine alone for the treatment of early recurrences   a systematic review. Transfusion. 2008;48(2):382-392.
                      of thombotic thrombocytopenic purpura. J Thromb Haemost.     213. Lapp H, Shin DI, Kroells W, et al. Cardiogenic shock due
                      2006;4(5):1162-1164.                                   to thrombotic thrombocytopenic purpura.  Z Kardiol.
                   196. Cataland SR, Jin M, Ferketich AK, et al. An evaluation of cyclo-  2004;93(6):486-492.
                      sporin and corticosteroids individually as adjuncts to plasma     214. Hasper D, Schrage D, Niesporek S, Knollmann F, Barckow
                      exchange  in  the  treatment  of  thrombotic  thrombocytopenic   D, Oppert M. Extensive coronary thrombosis in throm-
                      purpura. Br J Haematol. 2007;136(1):146-149.           botic-thrombocytopenic purpura.  Int J Cardiol. 2006;106(3):
                   197. Benhamou  Y,  Assie’  C,  Boelle  PY,  et  al.  Development and   407-409.
                      validation of a predictive model for death in acquired severe     215. Chang JC, Aly ES. Acute respiratory distress syndrome as a
                      ADAMTS13 deficiency-associated idiopathic thrombotic   major clinical manifestation of thrombotic thrombocytopenic
                      thrombocytopenic purpura: the French TMA Reference Center   purpura. Am J Med Sci. 2001;321(2):124-128.
                      experience. Haematologica. 2012;97(8):1181-1186.
                   198. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN.     216. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK,
                                                                             George JN. Complications of plasma exchange in patients
                      Disseminated malignancy misdiagnosed as thrombotic throm-  treated for clinically suspected thrombotic thrombocytopenic
                      bocytopenic purpura: a report of 10 patients and a systematic   purpura-hemolytic uremic syndrome. Transfusion. 2006;46(1):
                      review of published cases. Oncologist. 2007;12(1):11-19.  154-156.
                   199. Mead PS, Griffin PM. Escherichia coli O157:H7.  Lancet.     217. Chang JC, Gupta S. Acute respiratory distress syndrome and
                      1998;352(9135):1207-1212.                              non-occlusive mesenteric ischemia as major clinical manifes-
                   200. Ariceta G, Besbas N, Johnson S, et al. Guideline for the inves-  tations of thrombotic thrombocytopenic purpura: complete
                      tigation and initial therapy of diarrhea-negative hemolytic     remission following exchange plasmapheresis.  J Clin Apher.
                      uremic syndrome. Pediatr Nephrol. 2009;24(4):687-696.  1998;13(4):190-192.
                   201. Taylor CM, Machin S, Wigmore SJ, Goodship TH. Clinical     218. Beydoun A, Vanderzant C, Kutluay E, Drury I. Full neurologic
                      practice guidelines for the management of atypical haemolytic   recovery after fulminant thrombotic thrombocytopenic pur-
                      uraemic syndrome in the United Kingdom.  Br J Haematol.   pura with status epilepticus. Seizure. 2004;13(8):549-552.
                      2010;148(1):37-47.                                   219. Bilgir O, Bilgir F, Calan M, Kebapcilar L, Pamuk B, Yuksel A.
                   202. Loirat C, Fremeaux-Bacchi V. Atypical hemolytic uremic syn-  Treatment of status epilepticus with plasmapheresis in a patient
                      drome. Orphanet J Rare Dis. 2011;6:60.                 with  thrombotic  thrombocytopenic  purpura.  Transfus Apher
                   203. Tonshoff B, Sammet A, Sanden I, Mehls O, Waldherr R, Scharer   Sci. 2011;45(2):149-150.
                      K. Outcome and prognostic determinants in the hemolytic ure-    220. Garrett WT, Chang CW, Bleck TP. Altered mental status in
                      mic syndrome of children. Nephron. 1994;68(1):63-70.   thrombotic thrombocytopenic purpura is secondary to noncon-
                   204. Fitzpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt   vulsive status epilepticus. Ann Neurol. 1996;40(2):245-246.
                      TM. Atypical (non-diarrhea-associated) hemolytic-uremic syn-    221. Rizvi MA, Vesely SK, George JN, et al. Complications of
                      drome in childhood. J Pediatr. 1993;122(4):532-537.    plasma exchange in 71 consecutive patients treated for clinically
                   205. Noris M, Caprioli J, Bresin E, et al. Relative role of genetic   suspected thrombotic thrombocytopenic purpura-hemolytic-
                      complement abnormalities in sporadic and familial aHUS and   uremic syndrome. Transfusion. 2000;40(8):896-901.
                      their impact on clinical phenotype.  Clin  J  Am  Soc  Nephrol.     222. Creager AJ, Brecher ME, Bandarenko N. Thrombotic throm-
                      2010;5(10):1844-1859.                                  bocytopenic purpura that is refractory to therapeutic plasma
                   206. Zuber J, Le QM, Sberro-Soussan R, Loirat C, Fremeaux-Bacchi   exchange  in  two  patients with occult  infection.  Transfusion.
                      V, Legendre C. New insights into postrenal transplant hemolytic   1998;38(5):419-423.
                      uremic syndrome. Nat Rev Nephrol. 2011;7(1):23-35.    223. Kfoury  Baz  EM,  Khatib  MF,  Mahfouz  RA,  Jamaleddine  GW.
                   207. Saland JM, Emre SH, Shneider BL, et al. Favorable long-term   Deterioration  of  gas  exchange  in  patients  with  severe  throm-
                      outcome after liver-kidney transplant for recurrent hemolytic   botic thrombocytopenic purpura with respiratory failure during
                      uremic syndrome associated with a factor H mutation.  Am J   therapeutic plasma exchange. J Clin Apher. 2001;16(3):143-147.
                      Transplant. 2006;6(8):1948-1952.                     224. Askari S, Nollet K, Debol SM, Brunstein CG, Eastlund T.
                   208. Saland JM, Ruggenenti P, Remuzzi G. Liver-kidney transplan-  Transfusion-related acute lung injury during plasma exchange:
                      tation to cure atypical hemolytic uremic syndrome. J Am Soc   suspecting the unsuspected. J Clin Apher. 2002;17(2):93-96.
                      Nephrol. 2009;20(5):940-949.                         225. P’ng SS, Hughes AS, Cooney JP. A case report of transfusion-
                   209. Zuber J, Quintrec ML, Krid S, et al. Eculizumab for atypical   related acute lung injury during plasma exchange therapy
                      hemolytic  uremic  syndrome  recurrence  in  renal  transplanta-  for thrombotic thrombocytopenia purpura.  Ther  Apher  Dial.
                      tion. Am J Transplant. 2012;12(12):3337-3354.          2008;12(1):78-81.








          Section07-O-ref.indd   7                                                                                  1/21/2015   11:26:49 AM
   1317   1318   1319   1320   1321   1322   1323   1324   1325   1326   1327